Boston Partners
AGN

Boston Partners’s Allergan plc AGN Stock Holding History

Boston Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-425,297
Closed -$75.3M – 731
2020
Q1 		$75.3M Sell
425,297
-14,786
-3% -$2.78M 0.15% 170
2019
Q4 		$84.1M Sell
440,083
-43,290
-9% -$7.81M 0.11% 201
2019
Q3 		$81.4M Sell
483,373
-25,970
-5% -$4.23M 0.11% 205
2019
Q2 		$85.3M Sell
509,343
-26,946
-5% -$3.73M 0.11% 201
2019
Q1 		$78.5M Sell
536,289
-42,039
-7% -$6.09M 0.1% 202
2018
Q4 		$77.3M Buy
578,328
+559,045
+2,899% +$91.6M 0.11% 199
2018
Q3 		$3.67M Sell
19,283
-541
-3% -$99.4K ﹤0.01% 514
2018
Q2 		$3.31M Sell
19,824
-17,168
-46% -$2.76M ﹤0.01% 556
2018
Q1 		$6.22M Buy
36,992
+4,133
+13% +$693K 0.01% 434
2017
Q4 		$5.38M Sell
32,859
-2,976
-8% -$534K 0.01% 482
2017
Q3 		$7.34M Buy
35,835
+6,527
+22% +$1.52M 0.01% 439
2017
Q2 		$7.12M Hold
29,308
– – 0.01% 426
2017
Q1 		$7M Sell
29,308
-13,400
-31% -$3.12M 0.01% 442
2016
Q4 		$8.97M Buy
42,708
+21,508
+101% +$4.46M 0.01% 416
2016
Q3 		$4.88M Hold
21,200
– – 0.01% 497
2016
Q2 		$4.9M Sell
21,200
-927
-4% -$214K 0.01% 495
2016
Q1 		$5.93M Buy
+22,127
New +$6.33M 0.01% 443

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Boston Partners's AGN Position: Q2 2020 in Review

Boston Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 425,297 shares — an estimated $75.3M sold.

Boston Partners first reported a position in AGN in Q1 2016 and held it in 17 quarters. The position peaked at $85.3M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Boston Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Boston Partners sold 425,297 Allergan plc shares in Q2 2020, an estimated $75.3M.
  • Boston Partners first reported a position in Allergan plc in Q1 2016 and held it in 17 quarters.
  • Boston Partners's Allergan plc position peaked at $85.3M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Boston Partners's 13F filing for Q2 2020, filed 12 Aug 2020.